Related references
Note: Only part of the references are listed.Native size-exclusion chromatography-mass spectrometry: suitability for antibody-drug conjugate drug-to-antibody ratio quantitation across a range of chemotypes and drug-loading levels
Jay Jones et al.
MABS (2020)
Antibody-Drug Conjugates: Future Directions in Clinical and Translational Strategies to Improve the Therapeutic Index
Steven Coats et al.
CLINICAL CANCER RESEARCH (2019)
Potentiation of PBD Dimers by Lipophilicity Manipulation
Thais Cailleau et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2019)
Synthesis and evaluation of pyrrolobenzodiazepine dimer antibody-drug conjugates with dual β-glucuronide and dipeptide triggers
Stephen J. Gregson et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Practical approaches for overcoming challenges in heightened characterization of antibody-drug conjugates with new methodologies and ultrahigh-resolution mass spectrometry
Olga V. Friese et al.
MABS (2018)
Characterization of 30 therapeutic antibodies and related products by size exclusion chromatography: Feasibility assessment for future mass spectrometry hyphenation
Alexandre Goyon et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2017)
Insights from native mass spectrometry approaches for top- and middle- level characterization of site-specific antibody-drug conjugates
Thomas Botzanowski et al.
MABS (2017)
Efficient Preparation of Site-Specific Antibody-Drug Conjugates Using Cysteine Insertion
Nazzareno Dimasi et al.
MOLECULAR PHARMACEUTICS (2017)
Effects of N-Glycan Composition on Structure and Dynamics of IgG1 Fc and Their Implications for Antibody Engineering
Hui Sun Lee et al.
SCIENTIFIC REPORTS (2017)
Effects of Drug-Antibody Ratio on Pharmacokinetics, Biodistribution, Efficacy, and Tolerability of Antibody-Maytansinoid Conjugates
Xiuxia Sun et al.
BIOCONJUGATE CHEMISTRY (2017)
Rapid characterization of biotherapeutic proteins by size-exclusion chromatography coupled to native mass spectrometry
Markus Haberger et al.
MABS (2016)
Antibody Glycosylation and Its Impact on the Pharmacokinetics and Pharmacodynamics of Monoclonal Antibodies and Fc-Fusion Proteins
Liming Liu
JOURNAL OF PHARMACEUTICAL SCIENCES (2015)
Glycosylation May Reduce Protein Thermodynamic Stability by Inducing a Conformational Distortion
Yulian Gavrilov et al.
JOURNAL OF PHYSICAL CHEMISTRY LETTERS (2015)
A rapid on-line method for mass spectrometric confirmation of a cysteine-conjugated antibody-drug-conjugate structure using multidimensional chromatography
Robert E. Birdsall et al.
MABS (2015)
Native mass spectrometry and ion mobility characterization of trastuzumab emtansine, a lysine-linked antibody drug conjugate
Julien Marcoux et al.
PROTEIN SCIENCE (2015)
Synthesis of a C2-aryl-pyrrolo[2,1-c][1,4]benzodiazepine monomer enabling the convergent construction of symmetrical and non-symmetrical dimeric analogs
Robert V. Kolakowski et al.
TETRAHEDRON LETTERS (2015)
Innovative Native MS Methodologies for Antibody Drug Conjugate Characterization: High Resolution Native MS and IM-MS for Average DAR and DAR Distribution Assessment
Francois Debaene et al.
ANALYTICAL CHEMISTRY (2014)
Measurement of in Vivo Drug Load Distribution of Cysteine-Linked Antibody-Drug Conjugates Using Microscale Liquid Chromatography Mass Spectrometry
Shawna Mae Hengel et al.
ANALYTICAL CHEMISTRY (2014)
Ado-trastuzumab Emtansine (T-DM1): An Antibody-Drug Conjugate (ADC) for HER2-Positive Breast Cancer
John M. Lambert et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Theory and practice of size exclusion chromatography for the analysis of protein aggregates
Szabolcs Fekete et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2014)
Development of a Native Nanoelectrospray Mass Spectrometry Method for Determination of the Drug-to-Antibody Ratio of Antibody-Drug Conjugates
Jia Chen et al.
ANALYTICAL CHEMISTRY (2013)
Mass spectrometry of glycans
Liang Han et al.
BIOCHEMISTRY-MOSCOW (2013)
A Potent Anti-CD70 Antibody-Drug Conjugate Combining a Dimeric Pyrrolobenzodiazepine Drug with Site-Specific Conjugation Technology
Scott C. Jeffrey et al.
BIOCONJUGATE CHEMISTRY (2013)
SGN-CD33A: a novel CD33-targeting antibody-drug conjugate using a pyrrolobenzodiazepine dimer is active in models of drug-resistant AML
May S. Kung Sutherland et al.
BLOOD (2013)
Native Intact Mass Determination of Antibodies Conjugated with Monomethyl Auristatin E and F at Interchain Cysteine Residues
John F. Valliere-Douglass et al.
ANALYTICAL CHEMISTRY (2012)
Protein instability and immunogenicity: Roadblocks to clinical application of injectable protein delivery systems for sustained release
Wim Jiskoot et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2012)
The discovery and development of brentuximab vedotin for use in relapsed Hodgkin lymphoma and systemic anaplastic large cell lymphoma
Peter D. Senter et al.
NATURE BIOTECHNOLOGY (2012)
Analytical methods for physicochemical characterization of antibody drug conjugates
Aditya Wakankar et al.
MABS (2011)
Mass Spectrometric Analysis of Intact Human Monoclonal Antibody Aggregates Fractionated by Size-Exclusion Chromatography
Basak Kukrer et al.
PHARMACEUTICAL RESEARCH (2010)
Fragmentation of a recombinant monoclonal antibody at various pH
Georgeen Gaza-Bulseco et al.
PHARMACEUTICAL RESEARCH (2008)
β-elimination and peptide bond hydrolysis:: Two distinct mechanisms of human IgG1 hinge fragmentation upon storage
Steven L. Cohen et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2007)
The impact of glycosylation on the biological function and structure of human immunoglobulins
James N. Arnold et al.
ANNUAL REVIEW OF IMMUNOLOGY (2007)
Non-enzymatic hinge region fragmentation of antibodies in solution
AJ Cordoba et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2005)
Analysis of the composition of immunoconjugates using size-exclusion chromatography coupled to mass spectrometry
AC Lazar et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2005)
Effects of drug loading on the antitumor activity of a monoclonal antibody drug conjugate
KJ Hamblett et al.
CLINICAL CANCER RESEARCH (2004)
Share Paper
